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Background: The many attempts to identify genes for bipolar disorder (BD) have met with limited
success, which has generally been attributed to genetic heterogeneity and small gene effects. However, it
is also possible that the categorical phenotypes used in genetic studies of BD are not the most
informative or biologically relevant. We have explored aspects of temperament as quantitative
phenotypes for BD through the use of the Temperament Evaluation of Memphis, Pisa, Paris, and San
Diego Auto-questionnaire (TEMPS-A), which is designed to assess lifelong, milder aspects of bipolar
symptomatology and deﬁnes ﬁve temperaments: hyperthymic, dysthymic, cyclothymic, irritable, and
anxious.
Methods: We compared temperament scores between diagnostic groups and assessed heritability in a
sample of 101 families collected for genetic studies of BD. A genome-wide SNP linkage study was then
performed in the subset of 51 families for which genetic data was available.
Results: Signiﬁcant group differences were observed between BD subjects, their ﬁrst-degree relatives,
and independent controls, and all ﬁve temperaments were found to be signiﬁcantly heritable, with
heritabilities ranging from 21% for the hyperthymic to 52% for the irritable temperaments. Suggestive
evidence for linkage was observed for the hyperthymic (chromosomes 1q44, 2p16, 6q16, and 14q23),
dysthymic (chromosomes 3p21 and 13q34), and irritable (chromosome 6q24) temperaments.
Limitations: The relatively small size of our linkage sample likely limited our ability to reach genome-
wide signiﬁcance in this study.
Conclusions: While not genome-wide signiﬁcant, these results suggest that aspects of temperament may
prove useful in the identiﬁcation of genes underlying BD susceptibility.
& 2013 Elsevier B.V. Open access under CC BY-NC-ND license.iversity of California
la, CA 92093, USA.
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Y-NC-ND license.1. Introduction
Many attempts have been made over the last few decades to
resolve the genetic architecture of bipolar disorder (BD) and to
identify genetic variants contributing to susceptibility. Linkage and
association studies have implicated numerous chromosomal
regions and candidate genes with signiﬁcant evidence for an
involvement in BD, yet the causal variants have remained elusive
(Serretti and Mandelli, 2008). These difﬁculties in identifying
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geneity and small gene effects. Recent genome-wide association
(GWA) studies of BD and subsequent large meta-analyses encom-
passing several thousand cases and controls have produced
signiﬁcant evidence for association to some interesting new
candidates, yet these loci explain only 1–2% of disease liability
(Baum et al., 2007; Ferreira et al., 2008; Psychiatric GWAS
Consortium Bipolar Disorder Working Group, 2011; Scott et al.,
2009; Sklar et al., 2008; Smith et al., 2009; Wellcome Trust Case
Control Consortium, 2007).
Another possible explanation for the difﬁculties encountered in
gene mapping is that the diagnostic systems used in genetic
studies of BD may not be optimal. While various affective traits
and disorders with a range of severity are often observed in the
families of BD probands (Gershon et al., 1982; Kelsoe, 2003; Price
et al., 1985), the current categorical diagnostic systems are limited
in their ability to adequately deﬁne this phenotypic variation.
Some have suggested that BD may be better conceptualized as part
of a continuous distribution of affective phenotypes ranging from
very mild, subclinical affective traits to severe affective psychoses.
This is consistent with a polygenic trait for which interactions
between many genes of small effect produce a continuous varia-
tion in phenotype (Akiskal, 1983; Akiskal et al., 1977; Akiskal and
Pinto, 2000; Kelsoe, 2003).
Temperament is a heritable personality factor that remains
stable over time and establishes a person's baseline level of mood,
reactivity, and energy (Goldsmith et al., 1987). While normal
variations in temperament exist within the population, it has been
suggested that a dysregulation of temperament is the fundamental
abnormality that predisposes to the development of bipolar
spectrum disorders, with more extreme variation in temperament
conferring greater risk and increased severity (Akiskal, 1995;
Akiskal, 1996; Akiskal and Akiskal, 1992; Akiskal et al., 1977). In
this model, temperament is inﬂuenced by numerous genes of
small effect, resulting in a continuous distribution of mood
regulation and reactivity, consistent with the observation of milder
forms of the bipolar phenotype in family members of probands
with BD and with a polygenic mode of transmission. Temperament
may thus be more sensitive and closer to the underlying biological
abnormalities and, as such, may be a powerful tool for identifying
the genetic underpinnings of BD.
Temperament can be assessed along several dimensions that
deﬁne qualitatively different aspects of affective regulation, each
of which may be associated with different sets of genes. The
Temperament Evaluation of Memphis, Pisa, Paris, and San Diego
Auto-questionnaire (TEMPS-A) is a self-report questionnaire
designed to quantify temperament and assess lifelong, milder
aspects of bipolar symptomatology (Akiskal et al., 2005a, 2005b).
Five temperaments are deﬁned by this scale: hyperthymic, dys-
thymic, cyclothymic, irritable, and anxious. The reliability and
internal consistency of the TEMPS-A is well documented, and
the temperaments are stable over time, with one study reporting
stability up to six years (Akiskal et al., 1998; Kawamura et al., 2010;
Perugi et al., 2012; Placidi et al., 1998a, 1998b). Several studies
have demonstrated the ability of temperament measures to pre-
dict risk for bipolar spectrum disorders and to discriminate
between affected subjects, healthy relatives of affected subjects,
and normal controls (Akiskal et al., 1977; Akiskal et al., 1985;
Cassano et al., 1992; Evans et al., 2005; Horwath et al., 1992;
Kesebir et al., 2005; Kovacs et al., 1994; Mendlowicz et al., 2005;
Vazquez et al., 2007). Different temperaments within BD have also
been associated with different clinical courses, rates of relapse,
and response to antidepressants (Cassano et al., 1989;
Koukopoulos et al., 1983; Perugi et al., 2012; Rihmer et al., 2010).
Here we have used the TEMPS-A to assess temperament as a
quantitative phenotype for BD and to explore the underlyinggenetic architecture of BD and other affective disorders. We
evaluated temperament scores for subjects with BD, major depres-
sive disorder (MDD), clinically unaffected relatives, and indepen-
dent control subjects. We have previously reported evidence for
the familiality of temperament in BD (Evans et al., 2005). We now
report evidence for heritability of all ﬁve temperaments in 101 BD
families and the results of a subsequent genetic linkage analysis of
51 families genotyped for a single nucleotide polymorphism (SNP)
linkage panel. While investigations of BD have recently moved
toward GWA, which has greater power to detect weak associations
to common variants, linkage remains a valuable tool in genetic
studies with the ability to detect the aggregate effects of multiple
rare and common variants within a gene or region, even with
different mutations conferring risk in different families.2. Methods
2.1. Subjects
Subjects from BD families were selected from three different
data sets collected for genetic studies of BD. The primary dataset
(University of California San Diego, UCSD) was recruited at one of
three sites (San Diego, Vancouver, and Cincinnati) as part of a
collaborative genetic linkage study of BD (Kelsoe et al., 2001). The
other two data sets were recruited at UCSD as part of the National
Institute of Mental Health (NIMH) Genetics Initiative for Bipolar
Disorder Waves 3 and 4 (Dick et al., 2003). Since the TEMPS-A was
only administered at the San Diego site of the NIMH consortium,
data was not available for the rest of the NIMH collection. Families
were ﬁrst identiﬁed through a proband diagnosed with bipolar I
disorder or bipolar II disorder (UCSD sample) or a bipolar I sibling
pair (Waves 3 and 4) (Dick et al., 2003). Each subject was
interviewed and diagnosed using either a modiﬁed version of
the Structured Clinical Interview for DSM-III-R (SCID; Spitzer et al.,
1992) or the Diagnostic Interview for Genetics Studies (DIGS;
Nurnberger et al., 1994). Interviewers were extensively trained,
and reliability was regularly tested and shown to be high. A panel
of clinicians reviewed the interview, medical records, and infor-
mation from family informants in order to make a ﬁnal DSM-IV
diagnosis. Control subjects were ascertained through advertising
by the UCSD Mental Health Clinical Research Center and screened
using the SCID for the absence of psychiatric illness. Blood was
drawn on all subjects for the establishment of lymphoblastoid cell
lines. All subjects provided written informed consent according to
procedures approved by the local Institutional Review Board of
each university.
The TEMPS-A was administered at the time of interview and
includes a total of 109 self-rated true/false questions (110 for
women) designed to assess the hyperthymic, dysthymic, cyclothy-
mic, irritable, and anxious temperaments with 21 questions (26 for
anxious) speciﬁc to each temperament subscale (Akiskal et al.,
2005a, 2005b). Question 84 from the irritable subscale was
excluded from our analyses because it applies only to women.
The TEMPS-A has been shown to have very good reliability and
internal consistency with the temperaments showing good stabi-
lity over time (Akiskal et al., 1998; Kawamura et al., 2010; Placidi
et al., 1998a, 1998b).
The ﬁnal sample included 670 subjects from 101 families with
TEMPS-A data available for 428 subjects with the following
diagnoses: 128 subjects (29.9%) with bipolar I (BDI), 40 (9.3%)
with bipolar II (BDII), 9 (2.1%) with schizoaffective disorder,
bipolar-type (SA-BP), 100 (23.4%) with recurrent major depression
(MDD-R), 18 (4.2%) with a single episode of major depression
(MDD-SE), 148 (28.5%) with no history of mood disorders, and 11
(2.6%) of unknown diagnoses. These data, along with the number
Table 1
Summary of the subjects and families included in the heritability and linkage
analyses.
Heritability Linkage
Family information
Number of families 101 51
Average size 6.6 7.0
Average generations 2.5 2.5
Relative pairs
Sibling 310 200
Half-sibling 13 9
Parent–child 764 424
Grandparent–grandchild 302 148
Avuncular 249 123
Cousin 75 25
Subjects
Total subjects 670 (428) 356 (236)
Bipolar disorder (BD) 200 (177) 127 (111)
Major depressive disorder (MDD) 133 (118) 74 (66)
No history of mood disorders 148 (122) 72 (56)
The numbers of subjects with TEMPS-A data in all subjects and across diagnostic
categories are indicated in parentheses. The BD group includes BDI, BDII, and SA-BP,
and the MDD group includes MDD-R and MDD-SE.
Fig. 1. Mean scores for each temperament are indicated by diagnostic group.
Ann indicates that a signiﬁcant difference was found across the four diagnostic
groups for the respective temperament.
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included an independent sample of 53 control subjects with
TEMPS-A data and no personal or family history of mental illness.
This sample is approximately 62% female with an average age at
interview of 45 (717). All subjects were Caucasians of European
ancestry.
2.2. Genotyping
Genotyping was performed by the Center for Inherited Disease
Research (CIDR) using the Illumina Inﬁnium HumanLinkage-12
panel containing 6090 SNP markers across the genome. A subset of
the families and were genotyped as part of a larger study of 972
European ancestry families that were evaluated for linkage to BD
(Badner et al., 2012). The 5670 autosomal and X-linked SNPs that
passed the initial quality control assessments by CIDR were
evaluated for missingness, allele frequency, and Hardy–Weinberg
equilibrium, and families were further assessed for relatedness,
Mendelian errors, unlikely genotypes, and ancestry, as described
in detail in elsewhere (Badner et al., 2012). Cleaned genotypes
were available for 261 subjects from 51 of our 101 UCSD and NIMH
families (see Table 1). The remaining 5642 SNPs were ordered on
the physical map according to Genome Build 36, and the deCODE
genetic map was used to estimate genetic map distances (Kong
et al., 2002). The ﬁnal SNPs had an average physical spacing of
490 kb and an average genetic spacing of 0.62 cM.
2.3. Statistics
Subjects diagnosed as BDI, BDII, or SA-BP had similar scores
across the temperaments and were combined into a BD group for
analysis. Subjects diagnosed with MDD-R or MDD-SE also had
similar temperament scores and were combined into an MDD
group. Unaffected relatives and independent controls subjects
were placed into the REL and CTL groups, respectively. Group
differences were evaluated using one-way ANOVA with diagnosis
as the grouping factor, and the Tukey HSD for unequal n's was
utilized as a post hoc test to compare speciﬁc groups.
Heritability (h2) estimates were computed using the variance
component method implemented in SOLAR v.4.3.1 (Almasy and
Blangero, 1998). Prior to analysis, all temperaments were trans-
formed using the inverse normal function, which corrected theslight deviations from normality that were observed in the
distributions of the raw data. Age at interview and gender were
explored as potential covariates and retained in the analysis when
signiﬁcant (po0.05).
Linkage analysis was performed using the inverse normal
transformed and covariate-adjusted residual temperament scores.
Two-point and multipoint log of the odds ratio (LOD) scores were
computed using MERLIN v.1.1.2 (Abecasis et al., 2002). Although
several different methodologies are available to assess linkage for
quantitative traits, the pedigree-wide regression method in MER-
LIN was selected because it has been shown to be more robust to
issues involving incomplete marker informativity and is appro-
priate for selected samples, allowing for the speciﬁcation of
population based parameters (Cordell, 2004; Schork and
Greenwood, 2004a, 2004b; Sham et al., 2002). Variance compo-
nent models were instead used for analyses of the X chromosome,
since the regression algorithm only supports the analysis of
autosomes. For comparison, nonparametric linkage analysis of
BD was performed using the SPairs statistic in MERLIN under two
diagnostic models: a narrow model that included BD only and a
broad model that included both BD and MDD. Multipoint identity-
by-descent matrices were generated at a 1 cM resolution, slightly
larger than the average spacing between SNPs. Since linkage
analysis of tightly linked loci can inﬂate LOD scores, we required
that the r2 value between markers be less than 0.1. As a correction
for multiple testing, genome-wide suggestive and signiﬁcant
thresholds were estimated for this sample using gene-dropping
simulations in MERLIN with 1000 permutations for each tempera-
ment and diagnostic category. The suggestive and signiﬁcant
thresholds for each temperament and diagnosis are as follows:
2.32 and 3.18 for hyperthymic, 2.36 and 4.17 for dysthymic, 2.19
and 4.04 for cyclothymic, 2.32 and 4.45 for irritable, 1.81 and 3.07
for anxious, 1.92 and 3.17 for BD, and 1.88 and 3.1 for BD+MDD,
respectively. This sample has 80% power to detect a locus explain-
ing 45% of the trait variance across the temperaments with a LOD
of 2.2.3. Results
The average temperament scores in subjects with BD and MDD,
along with their unaffected relatives (REL) and independent
controls (CTL), are shown in Fig. 1. Signiﬁcant group differences
(po0.001) were observed for all ﬁve temperaments as follows:
hyperthymic F¼10.0, dysthymic F¼37.6, cyclothymic F¼97.3,
irritable F¼55.0, and anxious F¼58.0. As shown in Table 2, post
hoc analyses of the dysthymic, cyclothymic, irritable, and anxious
temperaments all revealed signiﬁcantly higher scores for the BD
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temperament also discriminated the REL and CTL groups with
trends observed for the cyclothymic and anxious temperaments.
For the hyperthymic temperament, the CTL group scored signiﬁ-
cantly higher, with no signiﬁcant differences among the BD, MDD,
and REL groups observed. Among the 177 BD subjects, females
scored signiﬁcantly higher than males for the dysthymic (mean
10.4 vs. 7.8, po0.001) and anxious (mean 12.7 vs. 9.2, p¼0.001)
temperaments and signiﬁcantly lower for the hyperthymic tem-
perament (mean 8.1 vs. 10.4, p¼0.002). Age at onset of BD had a
mean of 21.3 (710.2) years in this sample and was found to have
negative correlations with all temperaments except hyperthymic
(r¼−0.31 to −0.39, po0.01). Data regarding current state was
available for only 99 of the 177 subjects with BD and only 48 of the
118 subjects with MDD. Of those with data, 44% of BD and 13% of
MDD subjects met full criteria or were symptomatic at the time of
interview. We compared the temperament scores of these subjects
with those that were in remission at the time of interview and
found no signiﬁcant differences (p40.05). Finally, neither disease
severity nor lifetime course (with vs. without full interepisode
recovery) was signiﬁcantly correlated with any of the tempera-
ments (p40.05).
All ﬁve temperaments were found to be signiﬁcantly heritable
in this sample, as shown in Table 3, with heritabilities ranging
from 21% for hyperthymic to 52% for irritable. Gender was found to
be a signiﬁcant covariate for all but the cyclothymic temperament.
Several groups have shown correlations between age at interview
and the various temperaments, and age was found to be a
signiﬁcant covariate for all but the hyperthymic temperament in
our analyses as well (Benazzi, 2009; Di Florio et al., 2010; Karam
et al., 2010). Prior to conducting the linkage analyses, we con-
ﬁrmed the heritability of these temperaments in the subset of 51
families with available genotype data. The dysthymic, cyclothymic,
irritable, and anxious temperaments produced similar heritability
estimates in the genotyped sample, whereas the heritability of
hyperthymic was substantially higher in the 51 genotyped families
than in the complete sample of 101 families (41% vs. 21%).Table 2
Post hoc analyses of group differences across the temperaments.
Hyperthymic Dysthymic Cyclothymic Irritable Anxious
BD vs. MDD ns 0.005 o0.001 o0.001 o0.001
BD vs. REL ns o0.001 o0.001 o0.001 o0.001
BD vs. CTL o0.001 o0.001 o0.001 o0.001 o0.001
MDD vs. REL ns o0.001 o0.001 0.002 o0.001
MDD vs. CTL o0.001 o0.001 o0.001 0.001 o0.001
REL vs. CTL 0.002 0.037 0.068 ns 0.062
All signiﬁcant and trend (po0.10) p values are indicated with nonsigniﬁcant
p values (p40.10) indicated by “ns”.
Table 3
Heritability estimates observed for the ﬁve temperaments in the 101 families.
Temperament N Informative pairs h2r7
Sib P–O Other
Hyperthymic 417 231 282 269 0.217
Dysthymic 406 230 284 274 0.297
Cyclothymic 408 229 292 277 0.467
Irritable 406 226 289 257 0.527
Anxious 347 174 238 186 0.367
Key: Sib¼sibling pairs; P–O¼parent-offspring pairs; other¼half-sibling, grandparent–gr
signiﬁcant covariates; SE¼standard error; variance¼the proportion of the trait varianc
indicated by “ns”.As shown in Fig. 2 and summarized in Table 4, linkage analyses
collectively identiﬁed several interesting regions across the tem-
peraments, though none reached the threshold of genome-wide
signiﬁcance. Summaries of all multipoint and two-point LOD
scores 41.0 are provided in Tables S1 and S2, respectively.
Suggestive evidence of linkage was observed for hyperthymic on
chromosomes 1q44, 2p16, 6q16, and 14q23, for dysthymic on
chromosomes 3p21 and 13q34, and for irritable on chromosome
6q24. The cyclothymic and anxious temperaments produced
several peaks with multipoint LOD scores 41.0, but none met
genome-wide suggestive criteria. Numerous two-point LOD scores
meeting genome-wide suggestive criteria were also observed for
all temperaments but hyperthymic (see Fig. 2 and Table S2), many
of which occurred in regions that produced only modest multi-
point LOD scores at best. No signiﬁcant overlap of linked regions
was observed between the temperaments.
Several genes of potential interest were identiﬁed beneath the
multipoint linkage peaks. The neurexin 1 gene (NRXN1), which
encodes a neuronal cell surface protein involved in cell adhesion
and synaptogenesis, is located under the hyperthymic peak on
2p16. Deletions within this gene have been associated with
schizophrenia and autism (Kim et al., 2008; Kirov et al., 2008;
Kirov et al., 2009; Szatmari et al., 2007; Walsh et al., 2008). The
SET domain containing 2 gene (SETD2), which encodes a protein
belonging to a class of huntingtin interacting proteins character-
ized by WW motifs, is located beneath the dysthymic peak on
3p21 (Faber et al., 1998). The metabotropic glutamate receptor
1 gene (GRM1), which plays a critical role in synaptic plasticity,
learning, and memory, is located directly beneath the irritable
peak on 6q24 (Conquet et al., 1994; Gil-Sanz et al., 2008). Coding
variants in this gene have recently been implicated in both
schizophrenia and BD (Frank et al., 2012). The synaptic nuclear
envelope protein 1 gene (SYNE1), which has recently been impli-
cated as a susceptibility gene for BD in a large, collaborative GWA
study, is also located within the 1-LOD interval of the irritable
peak (Psychiatric GWAS Consortium Bipolar Disorder Working
Group, 2011).
Suggestive evidence for linkage was also observed for BD on
chromosomes 9q31 and 22q11 and BD+MDD on chromosome
19q13. Genes of potential interest were also identiﬁed beneath
these peaks, such as the lipid phosphate phosphatase-related
protein type 1 gene (LPPR1) under the peak on 9q31, which is
involved in neuronal plasticity (Savaskan et al., 2004). The 22q11
region has featured prominently in linkage studies of both BD and
schizophrenia (Blouin et al., 1998; Edenberg et al., 1997; Gill et al.,
1996; Kelsoe et al., 2001; Lachman et al., 1997; Pulver et al., 1994;
Shaw et al., 1998). Deletions and microdeletions of this region are
associated with schizophrenia and the “chromosome 22q11.2
deletion syndrome”, which encompasses a wide range of pheno-
typic variability, including the DiGeorge and velocardiofacial
syndromes, and often presents with higher rates of schizophreniaSE P value Covariate P values Variance
Age Gender
0.10 0.011 ns o0.0001 0.05
0.11 0.0009 0.012 o0.0001 0.06
0.11 o0.0001 o0.0001 ns 0.12
0.11 o0.0001 o0.0001 0.013 0.13
0.13 0.0007 o0.0001 o0.0001 0.14
andchild, avuncular, and cousin pairs; h2r¼residual heritability after adjustment for
e explained by all signiﬁcant covariates. All nonsigniﬁcant p values (p40.05) are
Fig. 2. Results of the genome-wide SNP linkage scan in the 51 families for each of the ﬁve temperaments. The results from the analysis of BD diagnosis as a narrow (BD) and
broad (BD+MDD) phenotype in these families are provided for comparison. Multipoint results are shown in blue with two-point results shown in gray. LOD scores are
indicated on the y-axis, along with the name of the corresponding temperament or diagnostic category, and chromosomes are aligned along the x-axis end to end with the
p-terminus on the left and locations indicated at the top of the ﬁgure. Dashed horizontal lines indicate signiﬁcant and suggestive LOD score thresholds for each phenotype
based on simulation. Note that LOD score signiﬁcance thresholds for dysthymic, cyclothymic, and irritable were 44.0 and are not shown.
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et al., 1999; Papolos et al., 1996). Flanking the peak LOD score on
22q11 are the DiGeorge syndrome critical region gene 6 (DGCR6),
which may play a role in neural crest cell migration, and the
proline dehydrogenase (oxidase) 1 gene (PRODH), which encodes a
mitochondrial protein that catalyzes the ﬁrst step in proline
degradation. Both have been implicated as candidate genes for
schizophrenia (Guilmatre et al., 2009; Lang et al., 2007; Liu et al.,
2002a, 2002b). These regions did not overlap with any of those
observed for the temperaments.4. Discussion
Since BD patients display signiﬁcant clinical variability, which
may reﬂect underlying genetic heterogeneity, the use of the DSM
diagnosis of BD as a phenotype may not have the best power to
detect causal genes. We have explored the use of temperament as
a quantitative genetic trait inﬂuencing susceptibility to BD. In this
study, signiﬁcant group differences were observed across all ﬁve
temperaments with the dysthymic, cyclothymic, irritable, and
anxious scales in particular showing the expected trend of morepathological scores for BD subjects, followed by MDD, then
unaffected relatives, and ﬁnally controls. These results are con-
sistent with our previous study that reported evidence of famili-
ality for the ﬁve TEMPS-A scales in a sample of 28 overlapping
families (Evans et al., 2005). The hyperthymic scale revealed a
different pattern wherein controls scored signiﬁcantly higher than
all other groups, and BD subjects did not differ from their affected
or unaffected relatives. This pattern has been observed in several
other studies as well and may reﬂect the ability of the hyperthy-
mic temperament to detect a latent genetic vulnerability to
developing BD (Evans et al., 2005; Mendlowicz et al., 2005;
Vazquez et al., 2007). It should be noted, however, that mixed
results have been found for this temperament, with BD subjects
scoring highest in some studies (Chiaroni et al., 2005; Kesebir
et al., 2005). We also observed signiﬁcant gender differences for
the temperaments with females scoring higher for dysthymic and
anxious and males scoring higher for hyperthymic. While a similar
pattern has been observed in healthy subjects (Vazquez et al.,
2012), as well as in other studies of BD (Evans et al., 2005;
Greenwood et al., 2012a), a recent study of lithium response in
BD failed to ﬁnd gender differences for any of the temperaments,
although the sample was quite small (Rybakowski et al., 2013).
Table 4
Summary of all chromosomal regions with multipoint LOD scores reaching suggestive evidence for linkage.
Temperament or diagnosis Chr Location (cM/Mb) Peak LOD 1-LOD interval (cM/Mb) Nearest genes Nearby genes of interest
Hyperthymic 1q44 272/245.0 2.53 269–274/243.5–246.1 SCCPDH, AHCTF1
2p16 77/51.8 2.84 74–82/48.1–59.1 NRXN1
6q16 103/98.4 2.83 98–105/91.1–101.4 C6orf167, POU3F2, FBXL4 EPHA7, GRIK2
14q23 61/61.0 2.61 50–80/52.3–78.8 SYT16 SYNE2, ESR2, PSEN1, NRXN3
Dysthymic 3p21 71/47.0 2.74 62–71/36.5–51.7 NBEAL2, SETD2 CTNNB1
13q34 124/111.8 2.39 116–129/109.0–113.5 SOX1
Irritable 6q24 147/145.0 2.33 132–149/133.3–147.7 UTRN, GRM1 STXBP5, SYNE1
BD 9q31 103/102.5 2.20 101–109/100.0–108.2 LPPR1 GRIN3A
22q11 6/17.0 2.77 3–15/16.3–21.0 DGCR6, PRODH COMT
BD+MDD 19q13 67/45.2 2.42 63–84/41.6–55.7 PSMC4, ZNF546, ZNF780A ZDHHC8, MAPK1
Key: 1-LOD interval¼genetic and physical boundaries of LOD scores within one unit of the maximum; nearest genes¼genes immediately ﬂanking the peak LOD score, with
those of particular interest based on function or previous studies underlined; nearby genes of interest¼genes within the 1-LOD interval that are expressed in brain or have
been implicated in previous studies of psychiatric illness.
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have directly assessed the heritability of the TEMPS-A scales in
families with BD and other affective disorders. In addition to
demonstrating the familiality of temperament in this sample, we
have further shown that all ﬁve temperaments are signiﬁcantly
heritable and thus suitable quantitative phenotypes for genetic
analyses of BD susceptibility. In another study of temperament in
241 subjects from 31 extended Caucasian South African families,
heritabilities were estimated as 51% for hyperthymic, 29% for
dysthymic, and 75% for irritable (Savitz et al., 2008). Anxious
was not evaluated in this study, and cyclothymic was not found to
be heritable. The heritability estimate for dysthymic from this
previous study is identical to what we have found here, and both
estimates for irritable are very high. The heritability of hyperthy-
mic was signiﬁcantly higher in this previous study than in ours,
although we note that the heritability of this temperament in the
linkage families was substantially higher at 41%. Conversely, we
found cyclothymic to be quite heritable in our study at 46%. The
discrepancies in these heritability estimates are likely due not only
to differences in the two samples, both in terms of size and
composition, but are also likely attributable to the different
programs used for analysis. While the Savitz et al. study used
QTDT to estimate heritability as part of a genetic association
analysis, we have used the variance components method in SOLAR
for this purpose (Abecasis et al., 2000; Almasy and Blangero, 1998).
Despite these differences, there is consistent evidence for the
familiality and heritability of temperament across studies.
Few studies investigating temperament in BD through genetic
analyses have been published to date. One study of selected
candidate genes found suggestive associations for the BDNF
val66met and COMT val158met polymorphisms with the
hyperthymic and irritable temperaments, respectively (Savitz
et al., 2008). The genomic regions including these genes, 11p13
and 22q11, respectively, did not show any evidence of linkage to
the temperaments in this study, although the 22q11 region did
show suggestive evidence of linkage to BD, and the COMT gene is
located within the 1-LOD interval. A linkage study of the cyclothy-
mic temperament in 28 BD families identiﬁed a genome-wide
suggestive peak on chromosome 18p11 with a LOD of 2.7. While
we did not ﬁnd any evidence for linkage of cyclothymic to this
region in the current study, we note that this previous study
utilized microsatellite markers with an average spacing of 8 cM,
compared with the SNP linkage panel used here with 0.6 cM
spacing, and included far fewer families than the present study.
A more recent GWA study of 1263 independent BDI subjects
identiﬁed signiﬁcant associations for the hyperthymic tempera-
ment on chromosomes 12q15 and 22q13 in the MDM1 and FBLN1
genes, respectively, and for irritable on chromosome 1q32 in the
INST7 and DTL genes (Greenwood et al., 2012a). While we did notﬁnd evidence for linkage to 12q15 or 22q13 in this study, there
was some evidence to support the 1q32 region with a maximum
multipoint LOD of 1.83 observed for hyperthymic and suggestive
two-point LOD scores of 3.45 and 2.62 observed for dysthymic (see
Tables S1 and S2). Two other regions of interest from this GWA
study, 13q31 for cyclothymic and 13q33 for irritable, also produced
suggestive two-point LODs in this study. For the 13q31 region, a
LOD of 2.36 was observed for dysthymic, and LODs of 2.58 and 2.51
were observed for cyclothymic and irritable, respectively, in the
13q33 region (see Table S2). No other regions of overlap were
observed between these two studies. Of course, one might not
expect an association study of unrelated BDI subjects to produce
the same ﬁndings as a linkage study of BD that includes both
affected and unaffected family members and a broader deﬁnition
of BD (BDI, BDII, and SA-BP). This is especially true considering
that association studies are most appropriate for the detection of
common variation, while linkage studies are more suited to the
detection of rare variants or regions of allelic heterogeneity (Ott
et al., 2011).
Linkage studies of BD over the last two decades have revealed a
variety of chromosomal regions that may harbor susceptibility loci,
including chromosomal regions 4p16, 5p15, 6q21, 8q24, 10q26,
11p15, 12q24, 13q32, 17q25, 18p11, 18q22–23, 20q13, 21q22,
22q12–13, and Xq26 (Serretti and Mandelli, 2008), with one meta-
analysis emphasizing the 13q32 and 22q13 regions (Badner and
Gershon, 2002), another implicating the 9p22, 10q11, and 14q24–32
regions (Segurado et al., 2003), and a combined analysis emphasiz-
ing the 6q21 and 8q24 regions (McQueen et al., 2005). A recent
study of 972 bipolar families using this same SNP linkage panel
indicated the strongest ﬁndings for chromosomes 6q21 and 9q21
(Badner et al., 2012). Our previous linkage analyses of 20 extended
pedigrees for BD revealed strong evidence of linkage to chromosome
22q11, as well as suggestive evidence for linkage to 3p21, 3q27, 5p15,
10q, 13q31–q34, and 21q22 (Kelsoe et al., 1996; Kelsoe et al., 2001;
Lachman et al., 1997). Further analysis of an additional 34 pedigrees
found strong evidence for linkage to 6q25 and suggestive evidence
for 13q32 and 17p12 (Greenwood et al., 2012b; Shaw et al., 2003).
Of the 51 linkage families resented here, 28 overlapped with these
two previous studies. With the notable exceptions of 3p21 and
13q34, for which suggestive evidence for linkage to dysthymic was
observed, and 22q11, which showed suggestive evidence for BD,
none of these regions featured prominently in our analyses. How-
ever, suggestive two-point LOD scores were observed for the 6q21,
13q31, 13q33, 17q25, 18q11, and 22q13 regions across several
temperaments (see Table S2). The 6q16 linkage observed for the
hyperthymic temperament in this sample was also observed for BD
in both our previous study of 34 families and in the NIMH wave
3 sample, both of which overlap in part with the sample presented
here (Dick et al., 2003; Greenwood et al., 2012b).
T.A. Greenwood et al. / Journal of Affective Disorders 150 (2013) 1031–1040 1037One might expect that the temperaments with the highest
heritabilities would produce the strongest genetic signals, yet, as our
results demonstrate, this is not necessarily the case. Irritable had one
of the highest heritabilities in this study at 52% and yet only produced
one multipoint linkage signal meeting genome-wide suggestive cri-
teria. Conversely, hyperthymic produced at total four suggestive
linkage peaks despite having the lowest heritability in the study at
21%, although we note that the heritability of this temperament in the
linkage subset was substantially higher (41%). Both cyclothymic and
anxious, with heritabilities of 46% and 36%, respectively, failed to
produce a single linkage peak meeting genome-wide suggestive
criteria, while dysthymic produced two suggestive linkage peaks with
a lower heritability of 29%. These results illustrate that heritability
estimates are not perfect predictors of the potential ‘mapability’ of the
underlying genetic variants. A phenotype with a relatively low
heritability may exhibit large effects of a small number of genes,
which would facilitate mapping. Alternatively, a phenotype may be
highly heritable but also highly polygenic, similar to BD itself, which
would signiﬁcantly complicate gene mapping by producing low-level
signals across a multitude of genomic regions. It is also possible that
the hyperthymic and dysthymic temperaments are particularly asso-
ciated with a genetic vulnerability for BD and thus produced the
strongest ﬁndings in our study. This idea is supported by the ﬁndings
of a prospective study on the offspring and siblings of BD patients,
which showed that the hyperthymic and dysthymic temperaments
were present before a superimposed mood episode developed
(Akiskal et al., 1985). Other temperaments may instead be the result
of modifying factors that have little impact on BD susceptibility.
There are several limitations to this study. Though the TEMPS-A is
designed to assess temperament as a lifelong characteristic, with the
subscales demonstrating good stability over time (Kawamura et al.,
2010; Placidi et al., 1998a, 1998b), it is possible that the subject's self-
assessment might be inﬂuenced by state at the time of testing. Since
data regarding current state was only available for a subset of subjects
with BD or MDD, adjusting the temperament scores for state would
effectively eliminate a majority of subjects with mood disorders.
However, a comparison of subjects who met full criteria or were
symptomatic with those who were in remission at the time of
interview found no signiﬁcant group differences in temperament
scores. Another study of 1263 BD subjects observed only very minimal
differences in temperament scores between subjects who were
euthymic vs. depressed or manic at the time of testing (Greenwood
et al., 2012). It is also possible that other comorbid conditions,
particularly drug and alcohol abuse, may impact temperament scores,
although directionality would be difﬁcult to determine, since one's
temperament may just as likely predispose to such conditions. In any
case, we were unable to adjust the scores for other clinical factors,
since complete information was not available across the sample.
Additionally, with a linkage study of ﬁve temperaments, multiple
comparisons are an issue. Several studies of healthy controls and/or
subjects with BD and MDD have shown a pattern of strong correla-
tions between the dysthymic, cyclothymic, irritable, and anxious
temperaments with the hyperthymic temperament showing minimal,
if any, correlations with the other temperaments, a pattern we have
also observed here among the BD subjects and all subjects combined
(data not presented) (Bloink et al., 2005; Greenwood et al., 2012a;
Matsumoto et al., 2005; Perugi et al., 2012). It is thus difﬁcult to
determine the appropriate correction in this case, since four of the ﬁve
temperaments are highly correlated with one another. Finally, our
modest sample of 51 families lacks sufﬁcient power to reliably detect
loci with smaller effects in a linkage analysis. This may also explain
why no suggestive peaks for the cyclothymic and anxious tempera-
ments were observed in this study. Still, we have identiﬁed several
regions of potential interest for three of the temperaments meeting
genome-wide suggestive criteria, which were veriﬁed through
simulation.If more pathological temperament scores are associated with a
greater risk of developing BD, affective temperaments may repre-
sent the most prevalent phenotypic expression of the genes
underlying BD (Akiskal, 2002). The results of our analyses suggest
that measures of temperament may have utility in illuminating the
genetic architecture of BD. While the absence of signiﬁcant or
suggestive linkage signals for all temperaments may be an issue of
power deﬁciencies in our sample, it is also likely a reﬂection of the
genetic complexity of the temperaments. Despite these complex-
ities, we have identiﬁed several regions meeting genome-wide
suggestive criteria that provide support for several interesting
genes and chromosomal regions. The extent to which these
regions harbor speciﬁc mutations that are involved in BD suscept-
ibility, or the temperaments themselves, remains a topic for future
discussion. Aside from genomic considerations, the relatively high
heritabilities of the temperaments reported here are consistent
with their putative evolutionary signiﬁcance for our species,
which, for its survival, depends on leadership, exploration, avoid-
ance of danger, and emotions that signal anger and threat (Akiskal
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